| # | Drug | Count |
|---|---|---|
| 0 | I. V. FAT EMULSION | 3 |
| 1 | I.V. FAT EMULSION | 3 |
| 2 | 0XYGEN | 1 |
| 3 | 3% SODIUM CHLORIDE | 1 |
| 4 | ALBUTEROL SULFATE | 1 |
| 5 | CLASCOTERONE | 1 |
| 6 | ENSIFENTRINE | 1 |
| 7 | ESTRADIOL | 1 |
| 8 | FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE | 1 |
| 9 | ISOTRETINOIN | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | 3% SODIUM CHLORIDE | 1 | 0.0088 |
| 1 | I. V. FAT EMULSION | 3 | 0.0041 |
| 2 | CLASCOTERONE | 1 | 0.0007 |
| 3 | SODIUM CHLORIDE 0.65% | 1 | 0.0007 |
| 4 | ENSIFENTRINE | 1 | 0.0005 |
| 5 | TAMOXIFEN CITRATE | 1 | 0.0002 |
| 6 | MESNA | 1 | 0.0001 |
| 7 | FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE | 1 | 0.0000 |
| 8 | ISOTRETINOIN | 1 | 0.0000 |
| 9 | 0XYGEN | 1 | 0.0000 |
| # | Drug class | Count |
|---|---|---|
| 0 | Lipid Emulsion [EPC] | 3 |
| 1 | Androgen Receptor Inhibitor [EPC] | 1 |
| 2 | Estrogen [EPC] | 1 |
| 3 | Interleukin-12 Antagonist [EPC] | 1 |
| 4 | Interleukin-23 Antagonist [EPC] | 1 |
| 5 | Osmotic Laxative [EPC] | 1 |
| 6 | Phosphodiesterase 3 Inhibitor [EPC] | 1 |
| 7 | Phosphodiesterase 4 Inhibitor [EPC] | 1 |
| 8 | Retinoid [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Lipid Emulsion [EPC] | 3 | 0.0011 |
| 1 | Phosphodiesterase 3 Inhibitor [EPC] | 1 | 0.0002 |
| 2 | Androgen Receptor Inhibitor [EPC] | 1 | 0.0000 |
| 3 | Interleukin-12 Antagonist [EPC] | 1 | 0.0000 |
| 4 | Interleukin-23 Antagonist [EPC] | 1 | 0.0000 |
| 5 | Phosphodiesterase 4 Inhibitor [EPC] | 1 | 0.0000 |
| 6 | Estrogen [EPC] | 1 | 0.0000 |
| 7 | Retinoid [EPC] | 1 | 0.0000 |
| 8 | Osmotic Laxative [EPC] | 1 | 0.0000 |